Clinical Trials Directory

Trials / Completed

CompletedNCT05512429

Prognostic Value of Body Composition in Lung Cancer

Prognostic Value of Body Composition in Therapy-Naïve Patients With Non-Small Cell Lung Cancer

Status
Completed
Phase
Study type
Observational
Enrollment
83 (actual)
Sponsor
Marmara University · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

The effect of body composition on the survival rate is one of the research topics of interest in cancer patients and gaining attention in the last years. Body mass index is often used a proxy measure of total adiposity and previous studies examining the relationship between BMI and cancer outcomes have been showed distinct results . Obese patients with malignancies such as colorectal, breast, and pancreatic cancers, have been shown to have a worse prognosis than normal-weight patients . Nevertheless, obese patients with non small cell lung cancer(NSCLC) have been observed to have a better clinical outcome than normal/low-weight cancer patients . In this study, we examined the effects of subcutaneous adipose tissue, visceral adipose tissue and skeletal muscle volumes on survival in metastatic NSCLC patients under different treatment regimens. Since there is no standard method for adipose tissue measurement, we evaluated the abdominal cavity with multi-slice and single-slice computed tomography measurements.

Conditions

Interventions

TypeNameDescription
OTHERmeasured of body composition with computed tomographyMultislice and single-slice computed tomography images were used for assessment of body composition including visceral adipose tissue (VAT), subcutaneous adipose tissue (SAT), skeletal muscle mass volume (SMMV)

Timeline

Start date
2019-01-01
Primary completion
2019-06-01
Completion
2019-07-01
First posted
2022-08-23
Last updated
2022-08-23

Locations

1 site across 1 country: Turkey (Türkiye)

Source: ClinicalTrials.gov record NCT05512429. Inclusion in this directory is not an endorsement.